A Study of a New Drug Treatment for Acne
NCT01326780
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
431
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
1.2% JNJ 10229570-AAA
DRUG:
2.4% JNJ 10229570-AAA
DRUG:
3.6% JNJ 10229570-AAA
OTHER:
Vehicle control
Sponsor
Bausch Health Americas, Inc.